RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $920,347 | +263609.7% | 40,146 | +89.5% | 0.06% | +181.0% |
Q2 2023 | $349 | -65.9% | 21,183 | -63.1% | 0.02% | -66.7% |
Q1 2023 | $1,023 | -40.8% | 57,335 | -3.3% | 0.06% | -41.1% |
Q4 2022 | $1,727 | -99.9% | 59,298 | +14.5% | 0.11% | +28.9% |
Q3 2022 | $1,269,000 | +482.1% | 51,802 | -1.4% | 0.08% | +492.9% |
Q2 2022 | $218,000 | -64.5% | 52,519 | -1.5% | 0.01% | -57.6% |
Q1 2022 | $614,000 | +17.9% | 53,300 | +2.1% | 0.03% | +26.9% |
Q4 2021 | $521,000 | -18.5% | 52,212 | +6.7% | 0.03% | -23.5% |
Q3 2021 | $639,000 | +1.4% | 48,950 | +52.1% | 0.03% | 0.0% |
Q2 2021 | $630,000 | -6.5% | 32,193 | +1.6% | 0.03% | -15.0% |
Q1 2021 | $674,000 | – | 31,688 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |